Results 211 to 220 of about 1,318,825 (382)

Simultaneous Cadaver Pancreas Living-Donor Kidney Transplantation: A New Approach for the Type 1 Diabetic Uremic Patient

, 2000
Alan C. Farney, Eugene Cho, Eugene J. Schweitzer, Brian J. Dunkin, Benjamin Philosophe, John O. Colonna, Stephen C. Jacobs, Bruce E. Jarrell, John L. Flowers, Stephen T. Bartlett   +9 more
openalex   +2 more sources

269 Rare Case of Pulmonary Necrotic Rhodococcus Equi Infection in a Kidney Pancreas Transplant Recipient.

, 2020
K.O. Omar, Robert L. Bacallao
openalex   +2 more sources

Evaluation of the Therapeutic Potential of Bioactive Materials Based on a Complex of Oxidovanadium(IV) and Exopolysaccharide Levan in a Model of Insulin Resistance in Mice

ChemMedChem, EarlyView.
A low‐toxicity bioactive composition of oxidovanadium(IV) and exopolysaccharide levan is synthesized, characterized, and shown to reduce hyperglycemia, hypertriglyceridemia, and TyG index in a mice model of dexamethasone‐induced insulin resistance. Bioactive compositions containing vanadium complexes have been a viable strategy for constructing more ...
Amanda K. J. P. F. da Silva, Eucilene K. de L. B. Marques, Lidiane M. A. de Lima, Widarlane A. S. Alves, Dayane A. Gomes, Pedro L. Guzzo, Mônica F. Belian, Wagner E. Silva, Eduardo C. Lira   +8 more
wiley   +1 more source

Impact of Gastroparesis on Outcomes After Pancreas Transplantation. [PDF]

Transplant Direct
Fridell JA, Chen JM, Kerby EA, Marshall WA, Lutz AJ, Powelson JA, Mangus RS.   +6 more
europepmc   +1 more source

Utilization of the Pancreas From Donors With an Extremely High Pancreas Donor Risk Index: Report of the National Registry of Pancreas Transplantation. [PDF]

Transpl Int, 2023
Kaku K, Okabe Y, Kubo S, Sato Y, Mei T, Noguchi H, Tomimaru Y, Ito T, Kenmochi T, Nakamura M.   +9 more
europepmc   +1 more source

Pancreas and Islet Transplantation [PDF]

Canadian Journal of Diabetes, 2013
Breay W, Paty, Angela, Koh, Peter, Senior   +2 more
openaire   +2 more sources

Lower Dose‐Normalized Tacrolimus Exposure in CYP3A5*6 vs. *3 Loss‐of‐Function Allele Carriers: A Longitudinal Retrospective Real‐World Study in Kidney Transplant Recipients

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacogenomic research has historically focused on individuals of European ancestry, leading to the underrepresentation of genetic variants common in non‐European populations. This bias is exemplified by CYP3A5*6, a functionally consequential variant common in individuals of African ancestry (MAF: 11–19%) but virtually absent in Europeans (MAF: 0.15%)
Amar D. Levens, Dirk Jan A. R. Moes, Yanick Boer, Aiko P. J. de Vries, Dorottya K. de Vries, Danny van der Helm, Soufian Meziyerh, Dave L. Roelen, Stefan Böhringer, Teun Van Gelder, Jesse J. Swen   +10 more
wiley   +1 more source

Multimodality diagnostic imaging and role of interventional radiology in pancreas transplantation. [PDF]

Abdom Radiol (NY)
Torikai H, Swensson J, Fromke E, Hagspiel K, Angle J, Khot R.   +5 more
europepmc   +1 more source

Kidney and combined kidney and pancreas transplantation may be under-utilized in cystic fibrosis. [PDF]

Front Transplant, 2022
Woywodt A, Dhanda R, van Dellen D, So B, Bright-Thomas RJ.   +4 more
europepmc   +1 more source

Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real‐World Data

Clinical Pharmacology &Therapeutics, EarlyView.
A considerable number of oral antitumor therapeutics (OAT) has the potential for causing pseudo‐worsening of kidney function (PW) due to inhibition of renal creatinine secretion, i.e., kidney function is unaffected, while creatinine‐based calculation of glomerular filtration rate (eGFR) erroneously indicates an impaired kidney function.
Michael I. Sponfeldner, Pauline Dürr, Phyllis Lensker, Katja Gessner, Lisa Cuba, Rainer Fietkau, Markus F. Neurath, Bernd Wullich, Marianne Pavel, Carola Berking, Matthias W. Beckmann, Andreas Mackensen, Frank Dörje, Martin F. Fromm   +13 more
wiley   +1 more source